CJC-1295 + Ipamorelin — Dual Pathway GH Research
CJC-1295 is a GHRH analogue incorporating Drug Affinity Complex (DAC) technology for extended albumin binding, producing sustained GHRH receptor (GHRHR) activation on pituitary somatotrophs. Ipamorelin is a selective GHSR agonist — the most receptor-selective compound in the ghrelin mimetic class, with minimal off-target receptor activity at research concentrations.
The two compounds operate via distinct receptor systems: GHRHR (CJC-1295) and GHSR (Ipamorelin). Preclinical research has demonstrated that co-administration produces synergistic GH pulse amplitude compared to either compound in isolation. This dual-pathway approach is among the most-studied designs in growth hormone axis research.
For full mechanism, receptor pharmacology, and study summaries, see the CJC-1295 + Ipamorelin Researchers Guide. For research use only.
CJC-1295 + Ipamorelin Products
Pre-mixed blend supplied in boxes of 10 research-grade vials.
Why Researchers Choose Eternal Peptides
Janoshik-Verified Every Batch
HPLC purity and mass spec identity confirmed for both compounds in the blend. Sterility, endotoxin, and heavy metals tested. COA independently verifiable at janoshik.com.
Australian-Owned, ABN Registered
ABN-registered Australian business dispatching domestically. ABN shown on all invoices.
Wholesale Box Pricing
Pre-mixed blend in boxes of 10 vials. No need to source and combine compounds separately. Research procurement pricing.
1-2 Day Dispatch
Orders dispatched within 1-2 business days from Australia. COA included with every order.
Frequently Asked Questions
Where can I buy CJC-1295 + Ipamorelin in Australia? +
Eternal Peptides Wholesale is an Australian-owned, ABN-registered distributor supplying CJC-1295 + Ipamorelin for research purposes. CP10 (5mg/5mg, box of 10) is $643.50. Janoshik-verified with COA on product page. Dispatched within 1-2 business days. For research use only.
Why are CJC-1295 and Ipamorelin combined? +
CJC-1295 stimulates GH release via the GHRH receptor; Ipamorelin via the GHSR. These are distinct, complementary pathways. Co-administration research has shown synergistic GH pulse amplitude compared to either compound alone — making the combination one of the most studied dual-pathway approaches in GH axis research. For research use only.
How does CJC-1295 differ from Sermorelin? +
Both are GHRH analogues acting at GHRHR. Sermorelin is the shorter GHRH(1-29) fragment with a shorter half-life suited to pulsatile release studies. CJC-1295 incorporates DAC technology for albumin binding, extending its half-life significantly for sustained release research designs. See the Sermorelin page. For research use only.
How is the blend quality verified? +
Every batch is tested by Janoshik Analytical — HPLC purity and mass spectrometry identity for both CJC-1295 and Ipamorelin, sterility (USP), endotoxin (LAL), and heavy metals (ICP-MS). COA published on the product page and independently verifiable at janoshik.com. For research use only.
How quickly is CP10 dispatched? +
Orders are dispatched within 1-2 business days of payment confirmation from Australia. COA documentation is included with every order.